Accelerating U.K. healthcare research
Having trouble viewing this video? Watch it here.
Dedicated to advancing healthcare through digital biology, Cambridge-1’s first projects with AstraZeneca, GSK, Guy’s and St Thomas’ NHS Foundation Trust, King’s College London and Oxford Nanopore include developing a deeper understanding of dementia, cancer and other serious diseases, as well as accelerating drug discovery and genome sequencing.
Cambridge-1 brings together decades of NVIDIA’s work in accelerated computing, AI and life sciences into a single system, An NVIDIA DGX SuperPOD™ supercomputing cluster, it ranks among the worlds’ 50 fastest supercomputers and is powered by 100% renewable energy.
NVIDIA DGX SuperPOD™ delivers a turnkey AI data center solution that allows researchers to focus on insights instead of infrastructure. A full-stack data center platform with best-of-breed computing, network fabric, storage, and software tools, along with a white-glove implementation service, ensures results in weeks instead of months. Learn more about the technology powering Cambridge-1.
Sign up for the latest NVIDIA healthcare news, including updates on Cambridge-1.